Charles DeBattista
Associate Chair – Undergraduate Medical Education and Integration · Stanford Health Care
Credentials: · · ·
History
- Present
- Present
- Present
1989–1990
Research
Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression
New England Journal of Medicine · 2022 · 867 citations
Stanford Accelerated Intelligent Neuromodulation Therapy for Treatment-Resistant Depression
American Journal of Psychiatry · 2020 · 593 citations
Stanford Neuromodulation Therapy (SNT): A Double-Blind Randomized Controlled Trial
American Journal of Psychiatry · 2022 · 559 citations
33 papers
20 papers
16 papers
16 papers · 2 as a resident
15 papers
14 papers
14 papers
14 papers
Grants
- 1998–2007
General Clinical Research Center
National Center for Research Resources · M01
Project lead · $164K · Stanford University
Clinical trials
- 2012–2014
Principal investigator · Withdrawn · Phase 2
Stanford University
- 2008–2019
International Study to Predict Optimised Treatment - in Depression
Principal investigator · Unknown · Phase 4
BRC Operations Pty. Ltd.
- 2006–2009
rEEG Guided Pharmacotherapy of Subjects With Depression Treatment Failure
Principal investigator · Completed
MYnd Analytics
- 2006–2007
Ropinirole Controlled Release (CR) as an Adjunctive Agent in the Treatment of Major Depression
Principal investigator · Completed
Stanford University